ALNA - Allena Pharmaceuticals $2.8M direct offering

Allena Pharmaceuticals (NASDAQ:ALNA) enters a securities purchase agreement with an investor for the issuance and sale of an aggregate of ~1,436 shares of its Series D Convertible Preferred Stock, and ~1,436 shares of its Series E Convertible Preferred Stock in a registered direct offering for an aggregate gross proceeds of ~$2.8M. Company currently intends to use the net proceeds from the offering for working capital purposes which may include repayment of debt. Offering is expected to occur on May 4, 2022.

For further details see:

Allena Pharmaceuticals $2.8M direct offering